HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of hirsutism with spironolactone and with spironolactone plus dexamethasone].

AbstractBACKGROUND:
Spironolactone has an anti androgenic effect, inhibiting the binding of androgens to their receptor. This antagonistic effect is the basis for the use of spironolactone in the treatment of hirsutism.
AIM:
To study the effectiveness and safety of spironolactone in the treatment of hirsute women and of the association of spironolactone plus dexamethasone in the treatment of hirsutism with glucocorticoid sensitive hyperandrogenism.
PATIENTS AND METHOD:
Sixteen women (group 1) with peripheral hirsutism (defined as those with normal androgens levels, normal menstrual cycles and ovulation) and 24 women (group 2) with glucocorticoid sensitive hyperandrogenic hirsutism were studied. Group 1 was treated with spironolactone 50 mg hid and group 2 with same spironolactone dose plus dexamethasone 0.5 mg at 23 h during one month and 0.25 mg thereafter. Patients were followed during one year.
RESULTS:
After one year of treatment, a 54% reduction in Moncada hirsutism escore was observed in group 1 and 52% reduction in group 2. Observed secondary effects of spironolactone were increases in diuresis, fatigability, acne aggravation and seborrhea in two patients. Two additional patients had spotting. No secondary effect attributable to glucocorticoid use were observed.
CONCLUSIONS:
Spironolactone is effective and safe in the treatment of hirsutism. Androgenic supression did no increases its effectiveness, underscoring the peripheral anti androgenic activity os spironolactone.
AuthorsE Devoto, L Aravena, R Ríos
JournalRevista medica de Chile (Rev Med Chil) Vol. 128 Issue 8 Pg. 868-75 (Aug 2000) ISSN: 0034-9887 [Print] Chile
Vernacular TitleTratamiento del hirsutismo con espironolactona y con espironolactona más dexametasona.
PMID11129548 (Publication Type: Clinical Trial, Controlled Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Glucocorticoids
  • Mineralocorticoid Receptor Antagonists
  • Spironolactone
  • Dexamethasone
Topics
  • Adolescent
  • Adult
  • Dexamethasone (therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Glucocorticoids (therapeutic use)
  • Hirsutism (blood, drug therapy)
  • Humans
  • Mineralocorticoid Receptor Antagonists (therapeutic use)
  • Spironolactone (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: